tert-Butyl (3-bromo-2-chlorophenyl)carbamate

Catalog No. :
ACLXUY146
CAS No. :
1936387-71-1
Molecular Formula :
C11H13BrClNO2
Molecular Weight :
306.59

IUPAC Name:tert-butyl (3-bromo-2-chlorophenyl)carbamate

tert-Butyl (3-bromo-2-chlorophenyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$116.00Login to see priceIn stockIn stock
1g98%$362.00Login to see priceIn stockIn stock
5g98%$1117.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (3-bromo-2-chlorophenyl)carbamate
IUPAC Nametert-butyl (3-bromo-2-chlorophenyl)carbamate
Molecular FormulaC11H13BrClNO2
Molecular Weight306.59
SMILESO=C(OC(C)(C)C)NC1=CC=CC(Br)=C1Cl
InChI KeyZWHUVILJDOUGDP-UHFFFAOYSA-N
SynonymCarbamic acid, N-(3-bromo-2-chlorophenyl)-, 1,1-dimethylethyl ester;tert-Butyl (3-bromo-2-chlorophenyl)carbamate;1,1-Dimethylethyl N-(3-bromo-2-chlorophenyl)carbamate
CAS No.1936387-71-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLXUY146 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJRCF092 route compound structure diagram
    ACJRCF09256131-46-5 In Stock
  4. Then
  5. ACLXUY146 route product structure diagram
    ACLXUY1461936387-71-1 In Stock
Inquiry

2. ACLXUY146 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJRCF092 route compound structure diagram
    ACJRCF09256131-46-5 In Stock
  4. Then
  5. ACLXUY146 route product structure diagram
    ACLXUY1461936387-71-1 In Stock
Inquiry

Comments (0)